Administrative Core

行政核心

基本信息

项目摘要

SUMMARY – Administrative Core During the next stage of our AADCRC, we will work collaboratively to advance understandings about severity, threshold, and immunotherapy of peanut allergy. Our program in anchored by a clinical core (PATHWAYS) and two complementary research projects (ROSETTA and IMPALA). Accomplishing our overall aims and the specific aims of each project will require concerted efforts by all the investigators and staff in our AADCRC. Our Administrative Core will coordinate activities across PATHWAYS, ROSETTA, and IMPALA, in addition to managing communication and engagement with other AADCRC teams and the NIAID. The Administrative Core will ensure that our activities are synchronized both internally within our AADCRC and externally with the AADCRC network and NIAID. The Administrative Core will organize regular meetings for the key personnel of our center to coordinate research activities, troubleshoot challenges, and present results; build a database for unifying and sharing clinical study data within our AADCRC; organize biospecimen processing and allocation to research projects; and provide fiscal oversight for our center's research activities. It will also be responsible for handling conflict resolution should it be needed and organizing research-related travel and training. In summary, the Administrative Core will facilitate the organization, management, and operations of our AADCRC so that we can achieve our high-level expectations for our center's scientific work, governance, and management.
摘要-行政核心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Supinda Bunyavanich其他文献

Supinda Bunyavanich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Supinda Bunyavanich', 18)}}的其他基金

Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center
早期特应性系统生物学(SUNBEAM)分析和生物信息学中心
  • 批准号:
    10573523
  • 财政年份:
    2022
  • 资助金额:
    $ 0.13万
  • 项目类别:
Gut Microbiome Dynamics in Peanut Allergy
花生过敏中的肠道微生物动态
  • 批准号:
    9797739
  • 财政年份:
    2019
  • 资助金额:
    $ 0.13万
  • 项目类别:
Gut Microbiome Dynamics in Peanut Allergy
花生过敏中的肠道微生物动态
  • 批准号:
    10452592
  • 财政年份:
    2019
  • 资助金额:
    $ 0.13万
  • 项目类别:
Gut Microbiome Dynamics in Peanut Allergy
花生过敏中的肠道微生物动态
  • 批准号:
    10221469
  • 财政年份:
    2019
  • 资助金额:
    $ 0.13万
  • 项目类别:
Project 2: Innate Immune Pathways in Food-induced Anaphylaxis
项目 2:食物引起的过敏反应中的先天免疫途径
  • 批准号:
    10635815
  • 财政年份:
    2018
  • 资助金额:
    $ 0.13万
  • 项目类别:
Threshold, Severity, and Immunotherapy of Peanut Allergy
花生过敏的阈值、严重程度和免疫治疗
  • 批准号:
    10635811
  • 财政年份:
    2018
  • 资助金额:
    $ 0.13万
  • 项目类别:
Biomarkers and causal key drivers of phenotypic heterogeneity in peanut allergy
花生过敏表型异质性的生物标志物和关键驱动因素
  • 批准号:
    10415894
  • 财政年份:
    2018
  • 资助金额:
    $ 0.13万
  • 项目类别:
Project 1: Integrated Transcriptomics of Severity, Immunotherapy, and endotypes in Peanut Allergy
项目 1:花生过敏严重程度、免疫治疗和内型的综合转录组学
  • 批准号:
    10635814
  • 财政年份:
    2018
  • 资助金额:
    $ 0.13万
  • 项目类别:
Nasal biomarkers of asthma
哮喘的鼻生物标志物
  • 批准号:
    9152652
  • 财政年份:
    2015
  • 资助金额:
    $ 0.13万
  • 项目类别:
The Genetics and Genomics of Allergic Rhinitis
过敏性鼻炎的遗传学和基因组学
  • 批准号:
    8083690
  • 财政年份:
    2011
  • 资助金额:
    $ 0.13万
  • 项目类别:

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
  • 批准号:
    10934920
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
  • 批准号:
    10934926
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
  • 批准号:
    10945539
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
  • 批准号:
    10945543
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
  • 批准号:
    10934927
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
Core B-Clinical Data Collection and Management Core
核心 B-临床数据收集和管理核心
  • 批准号:
    10555683
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)
使用数字生物标志物和急诊科电子健康记录中的临床数据对创伤事件暴露后的 PTSD 风险进行护理点预后建模 (PREDICT)
  • 批准号:
    10884738
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
使用 CTCAE 和其他临床数据分析和解释 PRO-CTCAE,以表征药物耐受性
  • 批准号:
    10884103
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
  • 批准号:
    10934921
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
STSS TASK ORDER - NATIONAL CLINICAL DATA COLLABORATIVE (NACDAC)
STSS 任务单 - 国家临床数据协作组织 (NACDAC)
  • 批准号:
    10949868
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了